UPDATED May 02, 2024
Discover Canadian Pharmaceuticals & Biotech Growth Stocks that are on the TSX. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
GLOW | CA$0.025 | -16.7% | -50.0% | CA$2.0m | n/a | PS104.5x | n/a | n/a | ||
MJMJ | CA$0.005 | 0% | -50.0% | CA$460.3k | n/a | n/a | n/a | n/a | ||
LVT | CA$0.005 | 0% | -80.0% | CA$538.4k | n/a | n/a | n/a | n/a | ||
CFT | CA$0.045 | 0% | 50.0% | CA$2.7m | n/a | PS14.2x | n/a | n/a | ||
CURE | CA$0.015 | 0% | 50.0% | CA$1.4m | n/a | PE0.6x | n/a | n/a | ||
GABY | CA$0.005 | 0% | -50.0% | CA$3.7m | n/a | PE-0.09x | n/a | n/a | ||
CHOO | CA$0.005 | 0% | -92.3% | CA$2.3m | n/a | PE-0.1x | n/a | n/a | ||
CALI.X | CA$0.005 | 0% | 0% | CA$5.0m | n/a | PE-12x | n/a | n/a | ||
NLV | n/a | n/a | n/a | CA$1.5m | n/a | n/a | n/a | n/a | ||
CLC | CA$0.04 | -11.1% | -42.9% | CA$5.2m | n/a | PB0.4x | n/a | n/a | ||
REZN | CA$0.005 | 0% | 0% | CA$1.4m | n/a | PS2.4x | n/a | n/a | ||
MBI.H | CA$0.08 | 0% | n/a | CA$1.4m | n/a | PE-17.3x | n/a | n/a | ||
WLLW | CA$0.095 | 5.6% | -13.6% | CA$12.1m | n/a | PS10.3x | n/a | n/a | ||
BBM | CA$0.015 | 0% | -40.0% | CA$6.0m | n/a | PS20.8x | n/a | n/a | ||
WOLF | CA$0.78 | 6.8% | 11.4% | CA$24.2m | n/a | PE39.7x | n/a | n/a | ||
METX | CA$3.96 | 2.9% | n/a | CA$93.6m | n/a | n/a | n/a | n/a | ||
INNO | CA$0.27 | -1.8% | 25.6% | CA$75.8m | n/a | PS4.1x | n/a | n/a | ||
AVCN | CA$0.35 | 2.9% | -14.6% | CA$35.1m | n/a | PS2x | n/a | n/a | ||
TELO | CA$0.15 | -16.7% | -55.2% | CA$10.7m | n/a | PB8.9x | n/a | n/a | ||
GLAB | CA$0.50 | 0% | -19.4% | CA$44.3m | n/a | PE-5.8x | n/a | n/a | ||
PHRX | CA$0.03 | -14.3% | -57.1% | CA$3.1m | n/a | PE-0.2x | n/a | n/a | ||
TIUM.U | US$0.19 | 18.8% | 137.5% | US$59.9m | n/a | PB6.6x | S10.1% | n/a | ||
OILS | CA$0.14 | -3.4% | 250.0% | CA$23.1m | n/a | PE25.2x | n/a | n/a | ||
NGEN | CA$2.16 | 6.9% | 32.5% | CA$143.4m | CA$4.50 | PE-6.7x | n/a | n/a |